Article
Interferon lambda 4 genotypes and resistance-associated variants in patients infected with hepatitis C virus genotypes 1 and 3.
Hepatology (Baltimore, Md.) - 1 Jan 2016
Peiffer Kai-Henrik, Sommer Lisa, Susser Simone, Vermehren Johannes, Herrmann Eva, Döring Matthias, Dietz Julia, Perner Dany, Berkowski Caterina, Zeuzem Stefan, Sarrazin Christoph
Abstract excerpt
UNLABELLED: Single-nucleotide polymorphisms (SNPs) in the interferon lambda 4 (IFNL4) gene are predictors for treatment success in patients with hepatitis C virus (HCV) infection. For direct-acting antiviral combinations only weak association with IFNL4 SNPs was observed. Little is known about potential selections of resistance-associated variants (RAVs) by the IFNL4 genotype. This study analyzed the prevalence...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
